Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136373 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von César Jessé Enríquez-Rodríguez und 18 weiteren Autor:innen. Beteiligte Einrichtung: Hospital del Mar Research Institute, Servei de Pneumologia, Hospital del Mar, 08003 Barcelona, Spain. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Metabolomics, Metabolome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (ISCIII), SEPAR Grants.
Themen: COPD
Abstract (Originalsprache)
Chronic Obstructive Pulmonary Disease (COPD) is a complex condition with high mortality. Early identification of patients at increased risk of death remains a major clinical challenge. This pilot study aimed to explore whether plasma metabolomic profiling could aid in the prediction of long-term (7-year) mortality and provide insight into potential underlying mechanisms. Plasma samples from 54 randomly selected stable COPD patients were analyzed using both untargeted and semi-targeted LC-MS approaches. After excluding patients with unclear death data, non-COPD-related deaths and metabolomic outliers, 41 individuals were included in the final analysis. During follow-up, 13 patients (32%) died, and 28 survived. Univariate analysis identified 12 metabolites—mainly amino acids—that differed significantly between the two groups. Functional analysis suggested a significant disruption in energy production pathways. Predictive models developed using machine learning algorithms, consisting of either ten metabolites alone or nine metabolites plus FEV1, achieved high accuracy for 7-year mortality prediction, with the latter model performing slightly better. Internal validation was conducted using five-fold cross-validation. While exploratory, these findings support the hypothesis that early metabolic alterations, particularly in energy pathways, may contribute to long-term mortality risk in stable COPD patients, and could complement traditional prognostic markers such as FEV1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital del Mar Research Institute, Servei de Pneumologia, Hospital del Mar, 08003 Barcelona, Spain.
- MELIS Department, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
- Centro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES), ISCiii, 28029 Madrid, Spain.
- The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3525433, Israel.
- Servei de Pneumologia (Institut Clínic de Respiratori), Hospital Clínic-Fundació Clínic per la Recerca Biomèdica, Universitat de Barcelona, 08036 Barcelona, Spain.
- Servicio de Neumología, Hospital 12 de Octubre, 28041 Madrid, Spain.
ORCID-Profile: César Jessé Enríquez-Rodríguez, Rosa Faner, Ramon Camps-Ubach, Germán Peces-Barba, Oswaldo Antonio Caguana-Vélez, Diego Rodríguez-Chiaradia, Borja G Cosío, Carme Casadevall
Förderung
- Spanish Ministry of Economy and Competitiveness
- Instituto de Salud Carlos III (ISCIII)
- SEPAR Grants
- SOCAP Grant
- Menarini Spain
- ISCIII
Zitieren
APA
Enríquez-Rodríguez, C. J., Agranovich, B., Pascual-Guàrdia, S., Faner, R., Camps-Ubach, R., Castro-Acosta, A., López-Campos, J. L., Peces-Barba, G., Seijo, L., Caguana-Vélez, O. A., Rodríguez-Chiaradia, D., Barreiro, E., Monsó, E., Cosío, B. G., Abramovich, I., Agustí, A., Casadevall, C., Gea, J., & On Behalf Of The Biomepoc Group (2025). Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136373
Vancouver
Enríquez-Rodríguez CJ, Agranovich B, Pascual-Guàrdia S, Faner R, Camps-Ubach R, Castro-Acosta A, et al. Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136373
BibTeX
@article{EnrquezRodrguez2025,
author = {Enríquez-Rodríguez, César Jessé and Agranovich, Bella and Pascual-Guàrdia, Sergi and Faner, Rosa and Camps-Ubach, Ramon and Castro-Acosta, Ady and López-Campos, José Luis and Peces-Barba, Germán and Seijo, Luis and Caguana-Vélez, Oswaldo Antonio and Rodríguez-Chiaradia, Diego and Barreiro, Esther and Monsó, Eduard and Cosío, Borja G and Abramovich, Ifat and Agustí, Alvar and Casadevall, Carme and Gea, Joaquim and On Behalf Of The Biomepoc Group},
title = {Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136373}
}
EUVIMED